Author

Rebecca R. Florke Gee

Texas Tech UniversityORCID 0000-0002-4736-3154Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Assay:metabolomics· 1 Assay:proteomics· 1

Frequent Co-Authors

Klementina Fon TaceriD· 2 shared Maria Camila Hoyos Sanchez· 2 shared Patrick Ryan PottsiD· 2 shared Sima Tozandehjani· 2 shared Anna K. LeeiD· 1 shared Barbara BreznikiD· 1 shared Barbara Breznik Vittori· 1 shared Denis ŠtepihariD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Klementina Fon TacerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Testis-Specific MAGEA3/6 Regulate Glycolysis to Promote Metabolic Flexibility and Reveal Therapeutic Vulnerabilities in Pancreatic Cancer Cells

Sima Tozandehjani, Vesna Jurjevič, Barbara Breznik Vittori, Juan Sebastián Solano-Gutiérrez, Rebecca R. Florke Gee, Denis Štepihar, Maria Camila Hoyos Sanchez, Sara Uhan, Jerneja Koren, Lara Snoj, Emily Ballard, Jesenia M. Perez, Menglin Jiang, Miloš Vittori, Patrick Ryan Potts, Klementina Fon Tacer

This study shows that MAGEA3/6 proteins in pancreatic cancer cells enhance metabolic flexibility by regulating glycolysis and mitochondrial metabolism, revealing therapeutic vulnerabilities.

bioRxiv · Oct 21, 2026 · PreprintCancer Biology

Melanoma antigens in pediatric medulloblastoma contribute to tumor heterogeneity and species-specificity of group 3 tumors

Rebecca R. J. Collins, Rebecca R. Florke Gee, Sima Tozandehjani, Tara Bayat, Maria Camila Hoyos Sanchez, Juan Sebastian Solano Gutierrez, Barbara Breznik, Anna K. Lee, Samuel T. Peters, Jon P. Connelly, Shondra M. Pruett‐Miller, Martine F. Roussel, Dinesh Rakheja, Heather S. Tillman, Patrick Ryan Potts, Klementina Fon Tacer

This study identifies MAGE antigens as markers of tumor heterogeneity and species-specificity in group 3 medulloblastoma, showing their role in cell survival and potential as therapeutic targets.

Acta Neuropathologica Communications · Jul 28, 2025Peer-reviewedCancer Biology